Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | Patent Publication Number 20110224194

US 20110224194 A1
Patent NumberUS 08222244 B2
Application Number13109511
Filled DateMay 17, 2011
Priority DateOct 30, 2001
Publication DateSep 15, 2011
Original AssigneeDanafarber Cancer Institute
Novartis
Current AssigneeNovartis
Inventor/ApplicantsJames Douglas Griffin
Paul William Manley
James D Griffin
Paul W Manley
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.